GS-0151

N/A

Report date: 2025/03/11 15:28:11

Base Information

Drug NameGS-0151
Drug Alias NameGS-0151MB-151
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProgrammed cell death protein 1 agonists
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsInflammationAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandGeorgia +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncMiroBio Ltd
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A